RHAG and breast carcinoma: They reported that Rh2 retarded the proliferation of the MCF-7 human breast cancer cell line in a dose-dependent manner by inducing changes in hypo-methylated genes involved in tumorigenesis with the upregulation of ST3GAL4, C1orf198 and CLINT1 [30].